The shortlist categories are divided into FOUR groups:

Excellence Categories – These categories look at achievements in our  core areas of excellence and include everything from Covid-19 Response to Social Impact.

Sector Excellence – These categories look at achievements within each individual market sub-sector and can include everything from notable business expansion through innovation to diversity and environmental initiatives.

Firms of the Year – These categories look at achievements by specific types of companies and includes everything from new market entrants to finance and legal firms.

Deals of the Year – The most notable finance and M&A deals from the research period.

 

*Please note that we also have awards for individuals, the winners of which will be announced in our Awards Report alongside the other category winners

Excellence Categories

BUSINESS EXPANSION

COVID-19 RESPONSE

  • Altimmune, DynPort
  • Bharat Biotech, Ocugen
  • CureVac
  • Destiny Pharma, SporeGen
  • Dynavax, Medigen
  • GlaxoSmithKline (GSK)
  • Intravacc, Celonic
  • Medicago
  • Moderna
  • Novartis, Molecular Partners
  • Oramed
  • Roche , Regeneron
  • SK, Novavax
  • Symvivo
  • Takeda
  • T-scan

ENVIRONMENTAL IMPACT

  • Alliance to Zero
  • Lloyd
  • The Sustainable Healthcare Coalition

INNOVATION

PRODUCT LAUNCH

  • Chief.AI
  • Dot Compliance
  • Genoskin
  • Hetero
  • Idifarma
  • Indivior
  • Merck

RESEARCH AND DEVELOPMENT

  • Adagio Therapeutics
  • Ampio
  • BioMarin, Deep Genomics
  • Codiak, Sarepta
  • CRUK, Teon
  • Oxford University
  • Pfizer , BioNTech
  • Scancell

SAFETY

  • ArisGlobal
  • TransPerfect

SOCIAL IMPACT

  • The Altrui Foundation
  • Galt Pharmaceuticals
  • NGM Biopharmaceuticals
  • Oximio

Sector Excellence

CARDIOVASCULAR

CENTRAL NERVOUS SYSTEM

  • AbbVie, Caraway
  • Biogen , Denali
  • Eli Lilly, Verge Genomics
  • Exscientia, Blue Oak
  • GlaxoSmithKline (GSK), Alector
  • Ipsen, Exicure
  • Janssen
  • PTC Therapeutics
  • Roche, UCB

CLINICAL TRIALS

  • AbbVie, Calico
  • CytoDyn, Biomm
  • Gilead, Novo Nordisk
  • Hoth Therapeutics, UCRI
  • Moderna
  • Novavax
  • Pfizer, BioNTech

DRUG DEVELOPMENT

  • Arcus Biosciences, WuXi Biologics
  • Arrowhead, Horizon
  • BioMarin
  • FUJIFILM Cellular Dynamics
  • GI Innovation
  • insitro
  • IQVIA
  • Merck
  • Roivant Sciences
  • UCB, Microsoft
  • Viking Therapeutics

IMMUNOLOGY

INFECTIOUS DISEASES

  • Exscientia
  • Gilead Sciences
  • Halozyme, ViiV Healthcare
  • Takeda, Frazier
  • Vaxart, Altesa

MANUFACTURING

  • Amgen
  • BioNTech, Novartis
  • Cellares, Poseida Therapeutics
  • Eisai, Seikagaku
  • Irisys
  • Moderna, Lonza
  • Regeneron
  • Samsung Biologics
  • Sandoz
  • Takeda
  • Thermo Fisher Scientific
  • VIVEbiotech
  • WuXi AppTec, OXGENE

ONCOLOGY

  • AbbVie, I-Mab
  • Arcus Biosciences, WuXi Biologics
  • AstraZeneca, Daiichi Sankyo
  • Bayer, Triumvira Immunologics
  • Bristol-Myers Squibb (BMS), Agenus
  • Boehringer, Enara Bio
  • Byondis, Glycotope
  • CRUK, Teon
  • Eisai, BMS
  • Gilead, Tango Therapeutics
  • HiFiBiO
  • Revitope Oncology
  • Pfizer
  • Rhizen, Curon
  • Twist, Neogene
  • Umoja Biopharma

RESPIRATORY

  • Icosavax
  • Moderna
  • Partner Therapeutics
  • Pieris, Genentech
  • Verona

SUPPLY CHAIN

  • CalAmp
  • Merck, BioNTech
  • USP

Firm of the Year

DISRUPTOR

  • Beam Therapeutics
  • BeiGene
  • Blueprint Medicines
  • ClouDr
  • Exscientia
  • Five Prime Therapeutics
  • GI Innovation
  • Insitro
  • Nvidia
  • Zymergen

FINANCE

  • Bank of America
  • Barclays
  • Centerview Partners
  • Citigroup
  • Cowen
  • Evercore
  • Guggenheim Partners
  • JPMorgan Chase & Co/J.P. Morgan Securities
  • Jefferies
  • Lazard
  • Morgan Stanley
  • The Goldman Sachs Group

LEGAL

  • Allen & Overy
  • Cooley
  • Cravath, Swaine & Moore
  • Davis Polk & Wardwell
  • Freshfields Bruckhaus Deringer
  • Fried, Frank, Harris, Shriver & Jacobson
  • Goodwin Procter
  • Kirkland & Ellis
  • Latham & Watkins
  • Ropes & Gray
  • Simpson Thacher & Bartlett
  • Wachtell, Lipton, Rosen & Katz

NEWCOMER

  • Alphazyme
  • Beam Therapeutics
  • Insitro
  • Recursion Pharmaceuticals
  • Relay Therapeutics

PRIVATE EQUITY/VC

  • Bain Capital
  • BC Partners
  • EQT Partners
  • Hellman & Friedman
  • Pamplona Capital Management
  • Partners Group
  • Permira
  • The Blackstone Group
  • The Carlyle Group

SME

  • Beam Therapeutics
  • Five Prime Therapeutics
  • GI Innovation
  • Insitro
  • Revitope Oncology
  • Unchained Labs
  • Viking Therapeutics

Deal of the Year

FINANCE

  • Biomat
  • Everest Med
  • Hepalink
  • Legend Bio
  • Relay Tx
  • Remegen
  • Simcere
  • Sotera Health

M&A (impact)

  • AstraZeneca acquires Alexion
  • Danaher acquires Aldevron
  • Gilead Sciences acquires Immunomedics
  • Horizon acquires Viela Bio
  • Eli Lilly acquires Prevail Therapeutics
  • Merck & Co. acquires VelosBio
  • Nestlé acquires Aimmune Therapeutics
  • PerkinElmer acquires BioLegend
  • Thermo Fisher Scientific acquires PPD